ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
New subgroup analysis from Phase III ARASENS trial shows that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel increased overall survival (OS)
eSanjeevani 2.0 will enhance the telemedicine experience further with a plethora of new features both in terms of technology as well as innovation
With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India
Subscribe To Our Newsletter & Stay Updated
